A baculovirus–insect cell whole-cell biocatalysis platform for NeuNAc biosynthesis

Industrial biocatalytic applications are frequently constrained by poor recombinant enzyme solubility and limited functional recovery in conventional microbial expression systems. To address this challenge, we developed a baculovirus–insect cell whole-cell biocatalysis platform and evaluated its feasibility using N-acetylneuraminic acid (NeuNAc) biosynthesis as a model system. Comparative analysis of three heterologous expression hosts— Escherichia coli , Pichia pastoris , and baculovirus-infected insect cells—showed that, under the baseline expression conditions evaluated in this study, insect cells provided higher soluble enzyme recovery and process-level bioconversion performance for GlcNAc 2-epimerase (2ep) and NeuNAc aldolase (NanA). Using baculovirus-infected Sf9 cells, both purified-enzyme and whole-cell configurations were established for sequential and one-pot biocatalysis. The whole-cell system enabled direct conversion without protein purification and achieved approximately 23% conversion to a product assigned as NeuNAc based on agreement of its HPLC retention time with that of an authentic standard under laboratory-scale one-pot conditions. Process optimization identified suitable conditions for suspension culture, infection, substrate concentrations, and catalyst loading, and the platform was further evaluated using cells produced in a 3-L bioreactor. In addition to simplifying catalyst preparation, the whole-cell strategy reduced the functional catalyst preparation requirements associated with purified-enzyme workflows. Although a comprehensive techno-economic assessment was beyond the scope of this work, a preliminary laboratory-scale cost estimation suggested lower raw material expenditure for the whole-cell workflow. Overall, this platform provides a proof-of-concept complementary strategy for biocatalytic applications in which enzyme solubility, folding, or functional expression limits the performance of conventional microbial hosts.

Authors

Institutions

Publication Details

Journal
Journal of Biological Engineering
Published
2026-09-17
DOI
https://doi.org/10.1186/s13036-026-00768-0
Primary Topic
Viral Infectious Diseases and Gene Expression in Insects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

A baculovirus–insect cell whole-cell biocatalysis platform for NeuNAc biosynthesis

Rong Huang, Hsin‐Yi Lee, Chia‐Yang Lin, Yueh‐Lung Wu et al.
Journal of Biological Engineering
Viral Infectious Diseases and Gene Expression in Insects
article

A baculovirus–insect cell whole-cell biocatalysis platform for NeuNAc biosynthesis

Rong Huang, Hsin‐Yi Lee, Chia‐Yang Lin, Yueh‐Lung Wu, Cheng‐Hsun Li, Yun Liu, Fang-er Li, Yao-Kuang Tseng, Hsiao-Ping Lee
article en

Abstract

Industrial biocatalytic applications are frequently constrained by poor recombinant enzyme solubility and limited functional recovery in conventional microbial expression systems. To address this challenge, we developed a baculovirus–insect cell whole-cell biocatalysis platform and evaluated its feasibility using N-acetylneuraminic acid (NeuNAc) biosynthesis as a model system. Comparative analysis of three heterologous expression hosts— Escherichia coli , Pichia pastoris , and baculovirus-infected insect cells—showed that, under the baseline expression conditions evaluated in this study, insect cells provided higher soluble enzyme recovery and process-level bioconversion performance for GlcNAc 2-epimerase (2ep) and NeuNAc aldolase (NanA). Using baculovirus-infected Sf9 cells, both purified-enzyme and whole-cell configurations were established for sequential and one-pot biocatalysis. The whole-cell system enabled direct conversion without protein purification and achieved approximately 23% conversion to a product assigned as NeuNAc based on agreement of its HPLC retention time with that of an authentic standard under laboratory-scale one-pot conditions. Process optimization identified suitable conditions for suspension culture, infection, substrate concentrations, and catalyst loading, and the platform was further evaluated using cells produced in a 3-L bioreactor. In addition to simplifying catalyst preparation, the whole-cell strategy reduced the functional catalyst preparation requirements associated with purified-enzyme workflows. Although a comprehensive techno-economic assessment was beyond the scope of this work, a preliminary laboratory-scale cost estimation suggested lower raw material expenditure for the whole-cell workflow. Overall, this platform provides a proof-of-concept complementary strategy for biocatalytic applications in which enzyme solubility, folding, or functional expression limits the performance of conventional microbial hosts.

Journal of Biological Engineering
National Taiwan University (TW), Bashkir Scientific Research Institute of Petroleum Refining (RU)
Openalex Percentile: Top 18%
Viral Infectious Diseases and Gene Expression in Insects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.